C000119619 Performance — MetLife Multi-Index Targeted Risk Portfolio, Class B
Data updated: 2026-08-27
C000119619 returned +5.90% year to date and +13.68% over one year to Jun 2026. Annualised returns are +9.39% over 3 years and +3.00% over 5 years. The fund trailed its US Large Blend category average: $100 invested three years ago grew to $131, against $157 for the category, and to $114 over one year, against $118. Volatility over the past three years was 11.95% a year. In the 12 months to Jun 2026 the fund lost a net $531.4M, and assets reached $5.42B.
C000119619 Growth of $100
What $100 invested in MetLife Multi-Index Targeted Risk Portfolio grew to, compounded from monthly returns reported on SEC Form N-PORT, against the US Large Blend category average over the same months.
| Period | C000119619 | Category average |
|---|---|---|
| 1 year (Jul 2025 – Jun 2026) | $114 | $118 |
| 3 years (Jul 2023 – Jun 2026) | $131 | $157 |
| 5 years (Jul 2021 – Jun 2026) | $116 | $161 |
| Since data start (Jul 2019 – Jun 2026) | $140 | $229 |
C000119619 Trailing Returns
Total returns to Jun 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +5.90% |
| 1 year | +13.68% |
| 3 years (annualised) | +9.39% |
| 5 years (annualised) | +3.00% |
C000119619 Annual Returns
Calendar-year total returns of MetLife Multi-Index Targeted Risk Portfolio, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jun) | +5.90% |
| 2025 | +9.07% |
| 2024 | +7.48% |
| 2023 | +13.84% |
| 2022 | −21.08% |
| 2021 | +9.72% |
| 2020 | +6.57% |
| 2019 (Jul–Dec) | +6.99% |
C000119619 Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +2.1% | +2.6% | −5.9% | +4.9% | +2.0% | +0.4% | — | — | — | — | — | — |
| 2025 | +2.6% | +1.1% | −2.8% | −2.6% | +0.8% | +2.6% | −0.2% | +3.1% | +2.3% | +1.2% | +0.9% | −0.2% |
| 2024 | −0.5% | +1.9% | +2.8% | −5.2% | +4.4% | +1.1% | +3.7% | +2.2% | +1.8% | −3.8% | +3.8% | −4.3% |
| 2023 | +5.9% | −3.5% | +3.2% | +1.1% | −2.1% | +3.5% | +1.8% | −2.6% | −5.5% | −3.7% | +9.3% | +6.9% |
| 2022 | −5.3% | −1.9% | −1.9% | −6.8% | +0.8% | −5.2% | +5.0% | −4.5% | −7.9% | +2.3% | +5.7% | −2.5% |
| 2021 | −0.9% | 0.0% | +0.9% | +3.1% | +1.3% | +1.1% | +1.6% | +1.3% | −3.7% | +3.6% | −1.5% | +2.6% |
| 2020 | +0.9% | −4.3% | −4.5% | +2.8% | +1.2% | +0.8% | +2.2% | +1.5% | −1.8% | −1.7% | +7.2% | +2.5% |
| 2019 | — | — | — | — | — | — | +0.4% | +1.0% | +0.8% | +1.6% | +1.6% | +1.4% |
C000119619 Risk
Risk measures from monthly returns over Jul 2023 – Jun 2026.
- 3-year volatility (annualised): 11.95%
- 3-year Sharpe ratio: 0.41 (vs 4.5% risk-free rate)
- Best month: +9.34% (Nov 2023)
- Worst month: −5.89% (Mar 2026)
C000119619 Fund Flows
Monthly money in and out of MetLife Multi-Index Targeted Risk Portfolio, from SEC Form N-PORT.
- 12-month net flow: −$531.4M
- 12-month gross sales (incl. reinvestments): $602.1M
- Sales ÷ redemptions: 0.53×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jun 2026 | $108.4M | $91.2M | $17.2M |
| May 2026 | $755K | $70.8M | −$70.1M |
| Apr 2026 | $487.1M | $62.8M | $424.2M |
| Mar 2026 | $600K | $74.9M | −$74.3M |
| Feb 2026 | $1.1M | $77.1M | −$76.1M |
| Jan 2026 | $408K | $76.1M | −$75.7M |
| Dec 2025 | $395K | $100.2M | −$99.8M |
| Nov 2025 | $546K | $100.1M | −$99.6M |
| Oct 2025 | $878K | $123.4M | −$122.5M |
| Sep 2025 | $358K | $108.5M | −$108.2M |
| Aug 2025 | $1.1M | $118.4M | −$117.2M |
| Jul 2025 | $483K | $129.9M | −$129.4M |
C000119619 Assets Under Management
Net assets of MetLife Multi-Index Targeted Risk Portfolio by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-06-30 | $5.42B |
| 2026-03-31 | $4.80B |
| 2025-12-31 | $5.09B |
| 2025-09-30 | $5.31B |
| 2025-06-30 | $5.39B |
| 2025-03-31 | $5.58B |
| 2024-12-31 | $5.76B |
| 2024-09-30 | $1.32B |
| 2024-06-30 | $1.26B |
| 2024-03-31 | $1.30B |
| 2023-12-31 | $1.29B |
| 2023-09-30 | $1.19B |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.